Tazemetostat hydrobromide

Drug ingredient

CAS 1467052-75-0

This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.

Molecular structure of 1467052-75-0
1 HBr
US productionNot reported
Top sourceNo public record

This chemical is not on EPA’s Toxic Substances Control Act inventory, the list behind EPA’s production survey.

Why supply is unknown

Where It Comes From

EPA and Census publish no US supply data for this chemical.

2 FDA-registered drug labelers
Epizyme, Inc.
Sterling Pharma Solutions Limited

Why It Matters

Sectors
Health
Downstream Uses

Appears in 1 drug and cosmetic product listings (FDA).

  • •Tazverik
FDA Shortage Status
No Shortage
Shortage History
  • to be discontinued

    Tazemetostat Hydrobromide Tablet

    Shortage listed since March 27, 2026

See all current drug shortages

Vendor Pricing

$342.00/gCombi-Blocks, Inc.
CountryUnited States
Pack$1710.00 / 5 g
Purity95%
Vendors12 available

Prices reflect listed pack sizes. Small research packs run far above bulk rates.

Chemical Identity

CAS1467052-75-0
PubChem CID71761627
DTXSIDDTXSID101027715
FormulaC34H45BrN4O4
Mol. Weight653.6 g/mol
SMILESCCN(C1CCOCC1)C2=CC(=CC(=C2C)C(=O)NCC3=C(C=C(NC3=O)C)C)C4=CC=C(C=C4)CN5CCOCC5.Br

Data Sources

Brief citations

Tazemetostat hydrobromide (CAS 1467052-75-0) https://chemicalindependence.com/chemical/1467052-75-0/ PubChem: 71761627. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/71761627 FDA National Drug Code directory: CAS 1467052-75-0. Retrieved 2026-04-25. https://open.fda.gov/data/ndc/ FDA Drug Shortages: CAS 1467052-75-0. Retrieved 2026-10-04. https://www.accessdata.fda.gov/scripts/drugshortages/